Medlumics is developing new medical devices for the treatment of Cardiac Rhythm Disturbances.
A pre-commercial device company, it designs and manufactures catheter-based systems for the treatment of supra-ventricular tachycardias.
Copyright © 2023 Seroba. All rights reserved.
Legal | Privacy | Sustainability
A pre-commercial device company, it designs and manufactures catheter-based systems for the treatment of supra-ventricular tachycardias.
Copyright © 2023 Seroba. All rights reserved.
Legal | Privacy | Sustainability
Location: Canada, Ontario, Ottawa
Employees: 11-50
Total raised: $85.21M
Founded date: 2009
Investors 7
Funding Rounds 5
| Date | Series | Amount | Investors |
| 10.02.2021 | - | $21.84M | - |
| 22.03.2017 | Series B | $37.12M | - |
| 25.03.2014 | - | $4.98M | - |
| 01.12.2011 | Series A | $4.72M | - |
| - | Series E | $16.56M | Asabys Par... |
Mentions in press and media 21
| Date | Title | Description |
| 13.11.2024 | Andera Partners continues its international expansion and announces the opening of a Madrid office | Gonzalo Boada joins Andera Partners as a Director within the Andera MidCap team, which invests in medium-sized companies (with revenue between €50 and €500 million) to accelerate their change of scale and their internationalization. The mai... |
| 11.02.2021 | MedLumics cierra una ronda de €18M a la que acuden Kurma Partners, VI Partners Swiss, CDTI, Asabys Partners, Andera Partners, Caixa Capital Risc e Innogest | 11/02/2021 Nota de prensa MEDLUMICS CIERRA UNA RONDA DE €18 MILLONES. PARTICIPAN, ENTRE OTROS, KURMA PARTNERS, CDTI, ASABYS PARTNERS, ANDERA PARTNERS, CAIXA CAPITAL RISC E INNOGEST. La empresa española de dispositivos médicos MedLumics h... |
| 10.02.2021 | MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman | MedLumics’ oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ablation catheter technology for the treatment of Atrial Fibrillation MedTech veteran, Rich Ferrari, joins MedLumics’ Board of Directors as n... |
| 10.02.2021 | MedLumics raises $21.8M to test its optically guided heart ablation catheter | MedLumics has raised €18 million, or about $21.8 million, to move toward clinically proving its optically guided heart ablation catheter for treating atrial fibrillation. Sponsored by Agilent Technologies How would you like to win free benc... |
| 10.02.2021 | MedLumics closes upsized EUR 18M financing round and appoints new Chairman | |
| 10.02.2021 | MedLumics raises $21.8M to test its optically guided heart ablation catheter | MedLumics has raised €18 million, or about $21.8 million, to move toward clinically proving its optically guided heart ablation catheter for treating atrial fibrillation. The Madrid-based company’s AblaView system is equipped with sensors t... |
| 10.02.2021 | MedLumics Closes Upsized EUR 18M Financing Round | MedLumics, a Madrid, Spain-based medical device company developing an optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), closed an upsized EUR 18m (USD 21.7m) financing round. Kurma Partners j... |
| 09.10.2020 | Medlumics cierra una ronda de financiación de €14M co-liderada por Asabys Partners, VI Partners y CDTI Innvierte, junto con los inversores actuales Andera Partners, Caixa Capital Risc e Innogest Capit... | Medlumics, desarrollador de Ablaview®, un sistema de ablación cardiaca por radiofrecuencia irrigada que combina fotónica e instrumentos ópticos mínimamente invasivos para guiar el posicionamiento del catéter y determinar la lesión en tiempo... |
| 09.10.2020 | Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest | Medlumics, which develops Ablaview®, a unique RF irrigated ablation catheter system that merges photonics and miniaturized optics to guide device placement and directly assess the ablation lesions in real time, announces today the closing o... |
| 08.10.2020 | Medlumics cierra una ronda de €14M co-liderada por Asabys Partners, VI Partners y CDTI Innvierte, junto con los inversores actuales Andera Partners, CaixaCR e Innogest Capital | 08/10/2020 Nota de prensa MEDLUMICS CIERRA UNA RONDA DE €14M CO-LIDERADA POR ASABYS PARTNERS, VI PARTNERS Y CDTI INNVIERTE, JUNTO CON LOS INVERSORES ACTUALES ANDERA PARTNERS, CAIXACR E INNOGEST CAPITAL. • Medlumics desarrolla un catéter ... |
Show more